Anabrez 1 Mg

Anabrez 1 Mg

Anabrez 1 Mg Tablet is used along with other therapies in the treatment of breast cancer in postmenopausal women. Anabrez 1 Mg Tablet is also used to treat women whose breast cancer has worsened after tamoxifen therapy.

Drug = Anastrozole

Strength = 1 Mg

Manufacturer = Sun Pharmaceutical Industries Ltd

How To Take

Anabrez 1 Mg is usually taken orally once per day or as directed by a doctor. The medication can be taken with or without food but should be taken with a full glass of water. Contact a doctor for the correct dosage and length of treatment as it will depend on the patient condition and their response to the therapy. Do not discontinue the treatment without consulting a doctor as some patients may require taking the tablets for up to 5 years.

Dosage

Anabrez 1 Mg

Side Effects

Headache

Hot flushes

Nausea

Skin rash

Musculoskeletal (bone, muscle or joint) pain

Osteoporosis

Weakness

Warning

Immediately proceed to your nearest emergency department if you suffer an allergic reaction. Symptoms usually associated with such a reaction include difficulty breathing or swallowing, chest tightness, swelling, skin rashes, and hives.

Anabrez 1 Mg is not always suitable for all patients. Always consult your health care provider prior to using this medication if you are pregnant, breastfeeding, trying to conceive, using any other medication (prescription or non-prescription), using any herbal products or supplements, or if you have any allergies or other health problems.

The correct dosage and prescription commonly depend on the patient and the condition being treated. Do not adjust your dosage without the approval of your health care provider. This product is only for use as prescribed and instructed.

Uses

Anabrez 1 Mg (Anastrozole) treats breast cancer by reducing the biosynthesis of estrogen, a hormone which can stimulate the growth and spread of this disease. The active ingredient in these tablets is classified as a non-steroidal aromatase inhibitor, and a key characteristic of its mechanism of action involves inhibiting the aromatase enzyme.

In postmenopausal women, the aromatase enzyme plays a central role in the production of estrogen, due to it converting various sex hormones (testosterone and androstenedione) into estrogen. Blocking the activity of the aromatase enzyme prevents this conversion process, resulting in decreased estrogen levels. Reducing the amount of estrogen in the body therefore helps prevent the growth of cancer cells in patients affected by hormone receptor positive breast cancer.